• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Michael Goldberg, PhD

Publications

  • Goldberg MS.siRNA Delivery for the treatment of ovarian cancer.Methods. 2013 Feb 10.
    23403216
  • Goldberg MS, Hook SS, Wang AZ, Bulte JW, Patri AK, Uckun FM, Cryns VL, Hanes J, Akin D, Hall JB, Gharkholo N, Mumper RJ.Biotargeted nanomedicines for cancer: six tenets before you begin.Nanomed. 2013 Feb;8(2):299-308.
    23394158
  • Goldberg MS, Sharp PA.Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression.J Exp Med. 2012 Feb 13;209(2):217-24.
    22271574
  • Goldberg MS, Xing D, Ren Y, Orsulic S, Bhatia SN, Sharp PA.Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells.Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):745-50.
    21187397
  • Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R, Borodovsky A, Borland T, Constien R, de Fougerolles A, Dorkin JR, Narayanannair Jayaprakash K, Jayaraman M, John M, Koteliansky V, Manoharan M, Nechev L, Qin J, Racie T, Raitcheva D, Rajeev KG, Sah DW, Soutschek J, Toudjarska I, Vornlocher HP, Zimmermann TS, Langer R, Anderson DG.A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.Nat Biotechnol. 2008 May;26(5):561-9.
    18438401
  • John M, Constien R, Akinc A, Goldberg M, Moon YA, Spranger M, Hadwiger P, Soutschek J, Vornlocher HP, Manoharan M, Stoffel M, Langer R, Anderson DG, Horton JD, Koteliansky V, Bumcrot D.Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway.Nature. 2007 Oct 11;449(7163):745-7.
    17898712